医学
生物吸附支架
组织学
他汀类
泌尿科
安慰剂
内科学
心脏病学
生物医学工程
外科
心肌梗塞
病理
经皮冠状动脉介入治疗
替代医学
作者
Philipp Nicol,Anna Bulin,Maria Isabel Castellanos,Magdalena Stöger,Simone Obermeier,Jonas Lewerich,Tobias Lenz,Petra Hoppmann,Christine Baumgartner,Johannes Fischer,Katja Steiger,Michael Haude,Michael Joner
出处
期刊:Eurointervention
[Europa Digital and Publishing]
日期:2020-12-01
卷期号:16 (11): e922-e929
被引量:8
标识
DOI:10.4244/eij-d-19-00747
摘要
Aims Neoatherosclerosis is a frequent finding after implantation of permanent metallic stents. Bioresorbable scaffolds (BRS) are considered to reduce the incidence of neoatherosclerosis owing to their dissolution and consequent vascular restoration. The aim of this study was to evaluate the formation of neoatherosclerosis between magnesium-based BRS and thick-strut metallic drug-eluting stents (DES) in a rabbit model of neoatherosclerosis and in proportion to the effect of high-dose statin medication. Methods and results Fully bioresorbable magnesium scaffolds (BRS, n=45) and thick-strut permanent metallic DES of equivalent geometry and design (n=45) were implanted into the iliac arteries of New Zealand White rabbits (n=45) following endothelial balloon injury and exposure to a cholesterol diet. Endothelialisation was assessed in 12 animals after 35 days using scanning electron microscopy (SEM), showing significantly enhanced re-endothelialisation above struts in the BRS (n=13) compared to DES (n=10). Eleven (11) animals were terminated for baseline assessment after 91 days while the remaining 22 animals were randomised to receive high-dose statin treatment (3 mg/kg) or placebo. BRS-treated vessels showed a significant reduction in foam cell infiltration as a sign of early neoatherosclerosis by histology and OCT when compared to thick-strut DES-treated vessels. Statin treatment resulted in significant reduction of foam cell infiltration in BRS and DES by histology. Conclusions Our findings suggest reduced neoatherosclerosis formation in magnesium-based BRS relative to thick-strut DES. High-dose statin treatment may be a promising measure to reduce neoatherosclerosis progression, both on its own and in synergy with site-targeted device-based treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI